Our Head of Medicinal Chemistry, Hiroki Yoshida, will be attending the 28th EFMC International Symposium on Medicinal Chemistry (September 1-5, 2024, Rome, Italy). Additionally, He will participate in the poster session on September 2 from 17:30 to 19:00 (local time).
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.